OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Monoclonal antibodies for malaria prevention
Maya Aleshnick, Melina Florez-Cuadros, Thomas Martinson, et al.
Molecular Therapy (2022) Vol. 30, Iss. 5, pp. 1810-1821
Open Access | Times Cited: 19
Maya Aleshnick, Melina Florez-Cuadros, Thomas Martinson, et al.
Molecular Therapy (2022) Vol. 30, Iss. 5, pp. 1810-1821
Open Access | Times Cited: 19
Showing 19 citing articles:
FDA-Approved Monoclonal Antibodies for Unresectable Hepatocellular Carcinoma: What Do We Know So Far?
Iason Psilopatis, Christos Damaskos, Anna Garmpi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2685-2685
Open Access | Times Cited: 15
Iason Psilopatis, Christos Damaskos, Anna Garmpi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2685-2685
Open Access | Times Cited: 15
Therapeutic development to accelerate malaria control through intentional intervention layering
Lydia Braunack-Mayer, Narimane Nekkab, Josephine Malinga, et al.
Malaria Journal (2025) Vol. 24, Iss. 1
Open Access
Lydia Braunack-Mayer, Narimane Nekkab, Josephine Malinga, et al.
Malaria Journal (2025) Vol. 24, Iss. 1
Open Access
Pharmacokinetic interaction assessment of an HIV broadly neutralizing monoclonal antibody VRC07-523LS: a cross-protocol analysis of three phase 1 trials in people without HIV
Tariro Dianah Chawana, Stephen R. Walsh, Lynda Stranix‐Chibanda, et al.
BMC Immunology (2025) Vol. 26, Iss. 1
Open Access
Tariro Dianah Chawana, Stephen R. Walsh, Lynda Stranix‐Chibanda, et al.
BMC Immunology (2025) Vol. 26, Iss. 1
Open Access
Malaria “chemoprevention and vaccination strategies” for children living in endemic areas of Africa: a review
Winnie Nambatya, Moses Ocan, Bjarne Robberstad, et al.
Frontiers in Malaria (2025) Vol. 3
Open Access
Winnie Nambatya, Moses Ocan, Bjarne Robberstad, et al.
Frontiers in Malaria (2025) Vol. 3
Open Access
Broadly inhibitory antibodies to severe malaria virulence proteins
Raphael A. Reyes, Sai Sundar Rajan Raghavan, Nicholas K. Hurlburt, et al.
Nature (2024)
Closed Access | Times Cited: 4
Raphael A. Reyes, Sai Sundar Rajan Raghavan, Nicholas K. Hurlburt, et al.
Nature (2024)
Closed Access | Times Cited: 4
A roadmap for understanding sulfadoxine-pyrimethamine in malaria chemoprevention
Thiey Masserey, Lydia Braunack-Mayer, Scott R. Miller, et al.
(2024)
Open Access | Times Cited: 1
Thiey Masserey, Lydia Braunack-Mayer, Scott R. Miller, et al.
(2024)
Open Access | Times Cited: 1
Recent advances, challenges and updates on the development of therapeutics for malaria.
Rimmy Nandal, Davinder Kumar, Navidha Aggarwal, et al.
PubMed (2024) Vol. 23, pp. 672-713
Closed Access | Times Cited: 1
Rimmy Nandal, Davinder Kumar, Navidha Aggarwal, et al.
PubMed (2024) Vol. 23, pp. 672-713
Closed Access | Times Cited: 1
Monoclonal antibody: future of malaria control and prevention
Shrikant Nema, Nitika Nitika
Transactions of the Royal Society of Tropical Medicine and Hygiene (2023) Vol. 117, Iss. 9, pp. 673-674
Closed Access | Times Cited: 4
Shrikant Nema, Nitika Nitika
Transactions of the Royal Society of Tropical Medicine and Hygiene (2023) Vol. 117, Iss. 9, pp. 673-674
Closed Access | Times Cited: 4
Potent AMA1-specific human monoclonal antibody against P. vivax Pre-erythrocytic and Blood Stages
Christopher L. King, Anna C. Winnicki, Melanie H. Dietrich, et al.
Research Square (Research Square) (2024)
Open Access
Christopher L. King, Anna C. Winnicki, Melanie H. Dietrich, et al.
Research Square (Research Square) (2024)
Open Access
Potent AMA1-specific human monoclonal antibody against P. vivax Pre-erythrocytic and Blood Stages
Anna C. Winnicki, Christopher L. King, Jürgen Bosch, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Anna C. Winnicki, Christopher L. King, Jürgen Bosch, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Application of machine learning in a rodent malaria model for rapid, accurate, and consistent parasite counts
Sean Yanik, Hang Yu, Nattawat Chaiyawong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Sean Yanik, Hang Yu, Nattawat Chaiyawong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
The revolutionary impact of monoclonal antibodies in malaria prevention
Vijay Kumar, Mahalaqua Nazli Khatib, Shilpa Gaidhane, et al.
Clinical Infection in Practice (2024) Vol. 24, pp. 100374-100374
Open Access
Vijay Kumar, Mahalaqua Nazli Khatib, Shilpa Gaidhane, et al.
Clinical Infection in Practice (2024) Vol. 24, pp. 100374-100374
Open Access
Harnessing monoclonal antibodies for malaria prevention in a paediatric population
Ayush Anand, Prakasini Satapathy, Mahalaqua Nazli Khatib, et al.
Tropical Doctor (2024) Vol. 54, Iss. 4, pp. 310-311
Closed Access
Ayush Anand, Prakasini Satapathy, Mahalaqua Nazli Khatib, et al.
Tropical Doctor (2024) Vol. 54, Iss. 4, pp. 310-311
Closed Access
Potent AMA1-specific human monoclonal antibody against Plasmodium vivax Pre-erythrocytic and Blood Stages
Anna C. Winnicki, Melanie H. Dietrich, Lee M. Yeoh, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
Anna C. Winnicki, Melanie H. Dietrich, Lee M. Yeoh, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
One Health Networks for Infectious Diseases Surveillance and Pandemic Preparedness in Central and South America
M. Claudia Guezala, Megan A. Schilling
The Journal of Infectious Diseases (2024) Vol. 231, Iss. Supplement_1, pp. S80-S85
Closed Access
M. Claudia Guezala, Megan A. Schilling
The Journal of Infectious Diseases (2024) Vol. 231, Iss. Supplement_1, pp. S80-S85
Closed Access
Monoclonals against malaria: the promise of passive protection
Merel J Smit, Matthew B. B. McCall
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 5, pp. 514-516
Closed Access | Times Cited: 1
Merel J Smit, Matthew B. B. McCall
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 5, pp. 514-516
Closed Access | Times Cited: 1
Monoclonal antibodies for the prevention of Plasmodium falciparum malaria: a multi-target approach?
Temi Lampejo
Infectious Diseases (2023) Vol. 56, Iss. 1, pp. 73-77
Closed Access | Times Cited: 1
Temi Lampejo
Infectious Diseases (2023) Vol. 56, Iss. 1, pp. 73-77
Closed Access | Times Cited: 1
Molecular therapies and vaccines face the challenges of emerging infectious diseases
Ami Patel, David B. Weiner, Weidong Xiao, et al.
Molecular Therapy (2022) Vol. 30, Iss. 5, pp. 1789-1790
Open Access | Times Cited: 2
Ami Patel, David B. Weiner, Weidong Xiao, et al.
Molecular Therapy (2022) Vol. 30, Iss. 5, pp. 1789-1790
Open Access | Times Cited: 2
Monoclonal antibodies for reducing malaria transmission
Claudia Daubenberger, Rajesh Gupta
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 11, pp. 1519-1520
Closed Access
Claudia Daubenberger, Rajesh Gupta
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 11, pp. 1519-1520
Closed Access
